On-demand Webinar: 2020 Social Determinants of Health Series–Assessing and Addressing Social Determinants of Health During a Pandemic
Join us for a webinar featuring KOLs emphasizing applied learnings in the SDOH and population health fields.
HLTH Conference Video: The Science & Politics of Developing a COVID-19 Vaccine & Treatment
Congratulations to Precision Medicine Group Co-Founder and CEO Mark Clein on his moderated Point: Counterpoint panel at this year’s HLTH Conference.
Driving Value in the Era of Biosimilars – What Payers & Manufacturers Can Do to Support Employers
The complexities and misaligned incentives within our healthcare system have affected the pace of biosimilar adoption in the US.
AJMC Center for Biosimilars: How to Encourage Biosimilar Uptake, Cultural Changes and Formulary Placement
A deep dive into the future of biosimilars: In this In this exclusive 2-part video interview for AJMC's Center for Biosimilars, editor Matthew Gavidia speaks with PRECISIONvalue's Ryan Cox to discuss what employers can do to encourage biosimilar uptake, the cultural changes that are needed to make it happen, and whether midsize employers can participate in payer discussions on formulary placement.
Charting A Course Into The Unknown: Manufacturer Considerations In Gene Therapy
The gene therapy market is still in its infancy but poised for significant growth, with an approximate 25% increase in therapies in the pipeline as compared to 2018. However, the launch of a gene therapy is an event with limited case examples to follow and numerous unique considerations.
The Importance of Crisis Management–Social Networking Strategies for Behavior Change in Vaccine Adoption
Precision's Maureen Hennessey discusses 3 crisis management-social networking strategies from the Ebola crisis that offer a playbook for addressing the current COVID-19 pandemic and infodemic, and its vaccine adoption.
On-demand Webinar: Wish I Knew Then What I Know Now–How Cell and Gene Therapies are Reshaping Commercialization Strategies
In this webinar, Carolyn Morgan of PRECISIONeffect moderates an expert panel exploring the challenges of commercializing a cell or gene therapy from industry trailblazers.
Value Transformation: Observations on the Third Annual Evaluation Report of the Oncology Care Model
The Centers for Medicare & Medicaid Services announced its third annual evaluation report of the Oncology Care Model in July 2020, covering performance periods 1-3 activities and results. Precision's Maureen Hennessey and Larry Blandford update observations from earlier reports.
